Using WallStreet VIPs' New Platform to Reach Wide Investor Audience
SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today that it will be delivering a live, virtual investor presentation, using WallStreet VIPs' new platform on April 29, 2008 at 1 PM Eastern Daylight Time (EDT).
NEW YORK, April 10 /PRNewswire-FirstCall/ -- "SPO Medical is a company on the move, though many investors still are not familiar with us," said Michael Braunold, President and Chief Executive Officer of SPO Medical. "We just reported our 2007 full year results with record sales; we added two new professional products, the finger PulseOx 6000(TM) and the hand-held PulseOx 6100(TM), and increased our network of distributors to 38 countries. Using WallStreet VIPs, we disseminate our story to the investor community broadcasting directly on the internet. It's a very effective way to reach out to the broader investor community, since presenters and investors can meet easily and conveniently from their respective offices."
"WallStreet VIPs is a 21st century productivity solution to the challenges of scheduling quality time for live meetings and provide great value added for every public company's comprehensive Investor Relations strategy in today's global village and permanent time constraints," stated Jerry Cahn, Ph.D., J.D., President of WallStreet VIPs. "Investor meetings are the life-blood of public companies. They enable the companies to maintain contact with the investor community educating and updating them on the company's business strategy and developments. CEOs traditionally engage in road shows traveling from city-to-city to meet investors impacting their time and attention that should be devoted to running their businesses."
For a free invitation to SPO Medical's virtual meeting, please register at http://www.WallStreetVIPs.com
About SPO Medical
SPO Medical (SPOM) a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-saving and life-enhancing information within four key markets: medical care; home and remote-care; sports and wellness; and safety and security. Its patented technology uses information gathered from the reflectance of light on the human blood stream, in a non-invasive manner, to monitor key vital signs. The Company distributes its products through a network of distributors and also licenses its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spomedical.com.
About Wall Street VIPs
WallStreet VIPs is the 21st century productivity solution to the challenges of scheduling quality time, live meetings with potential and existing investors. When integrated with face-to-face meetings for the most serious investors making commitments, VIPs become a key part of every company's comprehensive investor relations strategy. WallStreet VIPs coordinates the whole program, scheduling the event, inviting qualified investors, coaching the presenter on using the platform, helping make the investor presentation compelling and providing details on the attending audience. For details, see: http://www.WallStreetVIPs.com.
This press release contains forward-looking statements that involve
substantial uncertainties and risks. These forward-looking statements are
based upon our current expectations, estimates and projections about our
business and our industry, and that reflect our beliefs and assumptions
based upon information available to us at the date of this release. We
caution readers that forward-looking statements are predictions based on
our current expectations about future events. These forward-looking
statements are not guarantees of future performance and are subject to
risks, uncertainties and assumptions that are difficult to predict. Our
actual results, performance or achievements could differ materially from
those expressed or implied by the forward-looking statements as a result of
a number of factors, including but not limited to, changes in economic
conditions generally and the medical devices market specifically, changes
in technology, legislative or regulatory changes that affect us, the
availability of working capital, the introduction of competing products,
market acceptance of our new products, changes in our operating strategy or
development plans and the risks and uncertainties discussed under the
heading "Risk Factors" in Item 1 of our Annual Report on Form 10-KSB for
the fiscal year ended December 31, 2007. We undertake no obligation to
revise or update any forward-looking statement for any reason.
SPO Medical: Target 3 Communications:
Michael Braunold, President & CEO Eugene Feyman, Director
|SOURCE SPO Medical Inc.|
Copyright©2008 PR Newswire.
All rights reserved